ID   Mel Ch
AC   CVCL_B6KM
SY   mel Ch
DR   cancercelllines; CVCL_B6KM
DR   Wikidata; Q112129262
RX   CelloPub=CLPUB00680;
RX   Patent=RU2373279;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 706D.
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (CelloPub=CLPUB00680).
CC   Derived from site: Metastatic; Right axillary lymph node; UBERON=UBERON_0001097.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 05-10-23; Version: 5
//
RX   CelloPub=CLPUB00680;
RA   Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S.,
RA   Shubina I.Z., Kovalevsky D.A., Voronina E.S., Treshalina H.M.,
RA   Lushnikova A.A., Tsyganova I.V., Mazurenko N.N.;
RT   "Human skin melanoma cell lines collection.";
RL   (In) Management of malignant melanoma; pp.1-6; SM Group; Dover (2016).
//
RX   Patent=RU2373279;
RA   Mikhailova I.N., Baryshnikov A.Y., Demidov L.V., Kiselev S.L.,
RA   Burova O.S., Morozova L.F.;
RT   "Human melanoma cell line mel Ch, used for making anti-tumour
RT   vaccines.";
RL   Patent number RU2373279, 20-Nov-2009.
//